Carmot

Company Information
Address 409 Illinois Street
San Francisco, CA, -


Information

DUNS: 828863022

# of Employees: 5


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of

    Amount: $1,911,764.00

    DESCRIPTION: Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of cancer Project Summary/Abstract Protein-protein interactions represent the largest untapped opportunity f ...

    SBIRPhase II2013Department of Health and Human Services
  2. Discovery of biased small molecule agonists of the GLP-1 receptor for treatment o

    Amount: $541,527.00

    DESCRIPTION (provided by applicant): Type 2 diabetes mellitus is one of the most challenging health problems of the 21st century. Global health care expenditures to treat diabetes and its complication ...

    SBIRPhase I2012Department of Health and Human Services
  3. SBIR Phase II: A new drug discovery method to transform peptides to small molecules: proof of principle with p53-hdm2

    Amount: $500,000.00

    This Small Business Innovation Research (SBIR) Phase II project creates a powerful drug discovery technology that uses an innovative fragment-based approach to identify small molecule inhibitors of di ...

    SBIRPhase II2011National Science Foundation
  4. A novel approach to discover selective small molecule inhibitors of FABP4 and FAB

    Amount: $299,807.00

    DESCRIPTION (provided by applicant): A novel approach to discover selective small molecule inhibitors of FABP4 and FABP5 for the treatment of metabolic diseases The Western diet and lifestyle has brou ...

    SBIRPhase I2011Department of Health and Human Services
  5. Discovery of small molecule drug candidates that disrupt the NEMO/IKK signaling c

    Amount: $299,307.00

    DESCRIPTION (provided by applicant): Protein-protein interactions represent the largest untapped opportunity for therapeutic development. The number of protein-protein interactions in human cells has ...

    SBIRPhase I2010Department of Health and Human Services
  6. A new drug discovery method to transform peptides to small molecules: proof of principle with p53-hdm2

    Amount: $199,998.00

    This Small Business Innovation Research (SBIR) Phase I project will advance an innovative drug discovery technology to tackle important disease targets such as protein-protein interactions. Convention ...

    SBIRPhase I2010National Science Foundation

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government